comparison of the difference between dexatrol and prisoline and the best for eye infection

Comparing the difference between dexatrol and prisoline and the best for eye infection and eliminating infections and bacteria that infect them, they are one of the most famous effective antibacterial drops that treat the symptoms of eye infection such as redness and eye water, we will show the difference between dexatrol and prisoline drops and how to use them

Ingredients of dexatrol drops

dexatrol drops consist of the following active ingredients:

• Polymyxin B is an active substance belonging to the class of antibiotics known as polypeptides, which helps get rid of the types of bacteria that cause infection.
• Neomycin, a substance belonging to the class of antibiotics known as aminoglycosides, is used to eliminate types of bacteria that cause inflammation and infection.
• Dexamethasone, a substance belonging to the category of corticosteroid drugs, which works to reduce inflammation and the accompanying itching, redness and swelling.

prisoline drops ingredients

prisoline drops consist of the two active ingredients:

• Chlorpheniramine maleate, a substance belonging to first-generation antihistamines, which helps reduce the effect of histamine and thus works to relieve allergy symptoms of itching, tears and redness of the eye
• Naphazolin, an active substance belonging to the category of decongestants, which works to stimulate alpha-adrenergic receptors, and thus this helps to narrow the vessels and reduce inflammation and redness

Author Name: Pharmacist Nada Mohamed Mostafa

Scientific Degree: pharmacist

Country: Egypt

Clinical Pharmacist | Medical & Pharmaceutical Content Writer & Reviewer

A licensed Egyptian pharmacist registered with the Egyptian Pharmacists Syndicate, holding a Bachelor of Pharmaceutical Sciences (B.Pharm.) from the Faculty of Pharmacy, Cairo University in Pharmaceutical Chemistry. She possesses extensive hands-on experience in community pharmacy practice and clinical patient education, specializing in pharmacokinetics, drug-drug interactions, and evidence-based dosing guidelines for both adults and pediatrics.

Dr. Nada serves as a medical writer and reviewer at Rosheta, dedicated to simplifying complex pharmacological data for patients while delivering accurate, up-to-date clinical insights rooted in approved prescribing information and official regulatory standards, including the Egyptian Drug Authority (EDA) and the U.S. FDA.

Published Date: 28 April 2025